Health Canada has granted EndoChoice license to market its Fuse Full Spectrum Endoscopy system in Canada.
GI & Endoscopy
In a recent study published in The New England Journal of Medicine researchers led by Mark Sulkowski, MD, of Johns Hopkins University in Baltimore examined the outcomes of an oral combination therapy of declatasvir and sofosbuvir in patients infected with…
EndoChoice announced the launch of its Investigator-Initiated Study Program, which is designed to provide further clinical evidence for its Fuse Endoscopy System.
Stephen Lloyd, MD, PhD, board-certified in internal medicine, has been appointed to the American Association for Primary Care Endoscopy board of directors, according to a Columbia Star report.
Here are five current treatments for ulcerative colitis, according to Medscape's Treatment of Ulcerative Colitis report.
Advertisement
Gilbert Simoni, MD, of Los Robles Hospital in Thousand Oaks, Calif., and founder of Advanced Gastroenterology, Inc. recently performed his 100th transoral incisionless fundoplication (TIF) procedure. Here, Dr. Simoni discusses his experience performing TIF procedures and what he believes it…
EndoChoice announced the addition of Scott Davis, chairman and CEO of UPS, and Scott Huennekens, President and CEO of Volcano Corporation, to its board of directors.
Jason Tye-Din, MBBS, PhD, FRACP, and researchers at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, have developed a cytokine release test for celiac disease diagnosis, according to a Gastroenterology Update report.
Board-certified gastroenterologist Michael Uzer, MD, has joined the medical team at Sarah Bush Lincoln Health Center in Mattoon, Ill., according to a Journal Gazette & Times Courier report.
Researchers conducted a population-based cohort study of the risk of gastrointestinal and extraintestinal cancers in relation to Crohn's disease and ulcerative colitis. The results were published in the journal Clinical Gastroenterology and Hepatology.